Premium
Vulval intraepithelial neoplasia—management and outcome
Author(s) -
SHAFI M. I.,
BYRNE P.,
LUESLEY D. M.,
REDMAN C. W.,
ROLLASON T. P.,
SAMRA J. S.,
JORDAN J. A.
Publication year - 1989
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1989.tb03234.x
Subject(s) - outcome (game theory) , medicine , intraepithelial neoplasia , cervical intraepithelial neoplasia , cancer , prostate , cervical cancer , mathematics , mathematical economics
Summary Forty‐six patients with a primary diagnosis of vulval intraepithelial neoplasia (VIN) have been managed over a 10‐year period. The prevalence of VIN has increased and the age at presentation has decreased over the last decade; 59% of our patients had histological evidence of human papillomavirus infection. Pruritis was the commonest symptom at presentation (59%). Of the 46 patients 44 were treated by laser skinning vulvectomy, local excision or simple vulvectomy. Symptomatic relief was best achieved by local excision. Clinical and definitive relapse occurred more often in the laser‐treated group. The median time to relapse was 38 months in the laser‐treated group and 74 months in the surgically treated group (excision and simple vulvectomy). Two patients have not been treated and their disease has not progressed. The carbon dioxide laser almost certainly has a role in conservative management and although our data possibly do not reflect its full potential they demonstrate a need for a controlled prospective study.